UK markets open in 4 hours 42 minutes

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9314+0.0239 (+2.63%)
At close: 04:00PM EDT
0.9101 -0.02 (-2.29%)
After hours: 05:27PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.03-0.03-0.090.06
Low estimate-0.05-0.09-0.18-0.07
High estimate-0.010.030.050.14
Year ago EPS-0.04-0.03-0.14-0.09
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate33.42M39.83M149.11M191.16M
Low estimate29.78M32.3M126.9M160M
High estimate36.16M44.7M160.2M215.35M
Year ago sales26.89M27.2M116.88M149.11M
Sales growth (year/est)24.30%46.40%27.60%28.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.08-0.07-0.03-0.03
Actual EPS-0.04-0.030-0.05
Difference0.040.040.03-0.02
Surprise %50.00%57.10%100.00%-66.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.03-0.03-0.090.06
7 days ago-0.03-0.02-0.070.07
30 days ago-0.02-0.05-0.060.09
60 days ago-0.02-0.04-0.070.08
90 days ago-0.03-0.03-0.09-0.01
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days232N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesRIGLIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year35.70%N/AN/AN/A
Next year166.70%N/AN/AN/A
Next 5 years (per annum)70.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A